Rajangam Kanya
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1816676. Latest Form 4 filed Oct 23, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Senti Biosciences Holdings, Inc.SNTI | Pres. & Chief Med. & Dev. Off., Officer | 1 | 2026-10-21 | 2026-10-21 |
Transactions: 1
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-21 | Senti Biosciences Holdings, Inc.Pres. & Chief Med. & Dev. Off., Officer | Tax withholding | 19,953 | $0.00 | $0 | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 05:31 ET. Listed shows no prices and gives no investment advice.